Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 7/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MPO | P05164 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3291029 | 0.84 | HTR6 (0.62) | HTR6LMNAALDH1A1PKMKMT2A | |
| SCHEMBL17774709 | 0.78 | HTR6 (0.62) | HTR6TSHRLMNAMPOCYP3A4 | |
| SCHEMBL1703357 | 0.78 | HTR6 (0.60) | HTR6TSHRLMNAMPOCYP3A4 | |
| SCHEMBL8003877 | 0.77 | HTR6 (0.54) | HTR6TSHRLMNAMPOCYP3A4 | |
| SCHEMBL11079690 | 0.77 | MEN1 (0.55) | HTR6TSHRLMNAMPOCYP3A4 | |
| SCHEMBL26294642 | 0.77 | HTR6 (0.53) | HTR6TSHRLMNAALDH1A1PKM | |
| SCHEMBL324893 | 0.75 | HTR6 (1.00) | HTR6TSHRLMNAMPOCYP3A4 | |
| Dapsone SCHEMBL21428 | 0.75 | HTR6 (1.00) | HTR6TSHRLMNAMPOCYP3A4 | |
| Dapsone SCHEMBL1219599 | 0.75 | HTR6 (1.00) | HTR6TSHRLMNAMPOCYP3A4 | |
| Dapsone SCHEMBL5055312 | 0.75 | HTR6 (1.00) | HTR6TSHRLMNAMPOCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0145164-B1 | PROCESS FOR IMPROVING MOISTURE RESISTANCE OR EPOXY RESINS BY ADDITION OF CHROMIUM IONS | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1987-03-04 | — | — | EP | claimed |
| EP-0145164-A1 | Process for improving moisture resistance or epoxy resins by addition of chromium ions | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1985-06-19 | — | — | EP | claimed |
| US-4510277-A | AEROSPACE APPLICATIONS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1985-04-09 | — | — | US | claimed |
| WO-2014031923-A1 | COATED SUBSTRATES AND METHODS FOR PRODUCING THE SAME | MILLIKEN & COMPANY (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20140058026-A1 | COATED SUBSTRATES AND METHODS FOR PRODUCING THE SAME | MILLIKEN & COMPANY (US) | 2014-02-27 | — | — | US | disclosed |
| US-20110003955-A1 | Imide Oligomer And Polyimide Resin Obtained By Thermal Curing Thereof | DAIWA CAN COMPANY (JP) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003955-A1 | Imide Oligomer And Polyimide Resin Obtained By Thermal Curing Thereof | PUF60, SMARCC2, SMARCA4 | HTR6 4169/4885TSHR 4511/4885LMNA 3975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.